β III-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer-Reference-Cited by-同舟云学术

β III-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer

Published:2017-03 Issue: Volume:61 Page:210-220
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Hinsch Andrea,Chaker Aref,Burdelski Christian,Koop Christina,Tsourlakis Maria Christina,Steurer Stefan,Rink Michael,Eichenauer Till Simon,Wilczak Waldemar,Wittmer Corinna,Fisch Margit,Simon Ronald,Sauter Guido,Büschek Franziska,Clauditz Till,Minner Sarah,Jacobsen Frank

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference37 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

3. Pussycats and baby tigers: non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same!;Sauter;J Pathol,1998

4. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings;Bubendorf;Am J Clin Pathol,2001

5. Biomolecular predictors of urothelial cancer behavior and treatment outcomes;Rink;Curr Urol Rep,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas;Journal of Personalized Medicine;2023-10-18

2. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer;Cellular and Molecular Life Sciences;2023-08-30

3. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology;Pathology International;2023-08-17

4. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer;2023-05-03

5. Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site;Bioorganic & Medicinal Chemistry;2023-03